Imaging Diagnostic Research for Breast Cancer Presenting as Nonmass enhancement

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053730

Enrollment

Unknown

Registered

2021-11-28

Start date

2021-12-01

Completion date

Unknown

Last updated

2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:pathological results

Index test:Radiomics

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. There are pathologically confirmed benign and malignant lesions on DCE-MRI images; 2. No history of treatment or breast implants; 3. Not pregnant or breastfeeding; 4. DCE-MRI images showed non-mass-like enhancement.

Exclusion criteria

Exclusion criteria: 1. Poor image quality; 2. There is no non-mass-like enhancement on DCE-MRI images; 3. There is no pathological result after DCE-MRI examination.

Design outcomes

Primary

Measure	Time frame
Radscore;	—

Countries

China

Contacts

Public ContactXia Liming

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

xialiming2017@outlook.com+86 13607176908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026